OBIO - Orchestra BioMed Holdings, Inc. News

Discover

OBIO

Orchestra BioMed Holdings, Inc.

4.46

2 x 4.46

16 x 4.47

bid

ask

0.00

0.00%

01:34 PM

timesize

Ytd	7.47%
1y	76.98%

4.35

day range

4.63

2.20

52 week range

5.42

Open	4.35	Prev Close	4.46	Low	4.35	High	4.63	Mkt Cap	266.17M
Vol	215.74K	Avg Vol	322.30K	EPS	-0.97	P/E	-4.58	Forward P/E	-2.66
Beta	0.50	Short Ratio	12.51	Inst. Own	54.96%	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-06	50-d Avg	3.98	200-d Avg	4.17	1yr Est	15.60

OBIO News

zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.38 per share versus the

benzinga.com

Orchestra BioMed Hldgs Q2 EPS $(0.38) Misses $(0.37) Estimate, Sales $88.000K Miss $121.400K Estimat

Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.38) per share which missed the

defenseworld.net

Affinity Asset Advisors LLC Lowers Holdings in Orchestra BioMed Holdings, Inc. $OBIO

Affinity Asset Advisors LLC lessened its holdings in shares of Orchestra BioMed Holdings, Inc. (NASD

seekingalpha.com

Orchestra BioMed: Nearing The First Of Two Pivotal Readouts

Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with st

globenewswire.com

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

NEW HOPE, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

benzinga.com

12 Health Care Stocks Moving In Wednesday's After-Market Session

globenewswire.com

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

globenewswire.com

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orch

zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.33 per share versus the

globenewswire.com

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orch

globenewswire.com

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentat

NEW HOPE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orc

globenewswire.com

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Fi

NEW HOPE, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orc

globenewswire.com

Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Ag

Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet

globenewswire.com

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthro

globenewswire.com

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

NEW HOPE, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“O

zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with quarterly earnings of $0.26 per share, beating

globenewswire.com

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Updat

NEW HOPE, Pa., March 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“O

globenewswire.com

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive

NEW HOPE, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“O

defenseworld.net

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO - Get Free Report) have been assigned a cons

globenewswire.com

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

NEW HOPE, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

globenewswire.com

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW HOPE, Pa., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Or

defenseworld.net

AMH Equity Ltd Buys New Position in Orchestra BioMed Holdings, Inc. $OBIO

AMH Equity Ltd bought a new stake in Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) in the third qua

benzinga.com

Orchestra BioMed Anticipates Up To $21M In Cash Proceeds From Haemonetics Regarding Vivasure Acquisi

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company")),

benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com

12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com

This Applied Materials Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednes

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

benzinga.com

Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023

benzinga.com

Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday

U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here ar